Learn what andropause is, how doctors diagnose low testosterone, the blood tests used to confirm it and treatment options ...

FDA has approved Freenome's blood-based colorectal cancer screening test for older adults, paving ‌the way for partner Abbott ...

Blood cancers that eventually worsen may carry detectable genetic warning signs years before patients develop serious ...

Abbott will market Freenome’s SimpleScreen CRC test in the U.S., alongside its Cologuard stool test. SimpleScreen will ...

Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and ...

Astrin Biosciences, a cancer intelligence company transforming how cancer is detected and treated through deep proteomics and AI, today announced the publication of a landmark peer-reviewed study, ...

Fact checked by Elizabeth Gall Key Takeaways SimpleScreen CRC is a new FDA-approved blood test that screens for colorectal ...

SimpleScreen CRC is indicated for adults 45 and up at average risk ...

Guardant Health co-founder and co-CEO Helmy Eltoukhy discusses his company’s blood test for colorectal cancer on ‘The Claman ...

The FDA has approved Freenome’s new blood-based colorectal cancer test, SimpleScreen CRC, which Abbott will exclusively market in the U.S. Abbott will pay Freenome $100 million as part of a 2025 deal ...

Women who test negative for BRCA gene mutations may still be at greater risk of developing breast cancer than the general ...

The FDA has approved a second blood-based colorectal cancer screening option for adults aged 45 years and older at average ...